Security key
98420X202
X4 Pharmaceuticals, Inc - COMMON STOCK (XFOR)
CUSIP: 98420X202
Q3 2026 13F Holders as of 30 Sep 2026
- Security type / class
- Equity / COMMON STOCK
- Total 13F shares
- 1,174
- Total 13F value
- $3,405
- Share change
- +1,174
- SEC-reported price per share
- $2.90
- Number of holders
- 2
- Value change
- +$3,405
- Number of buys
- 2
- Shares outstanding
- 99,100,348
Holder snapshot
5 signals
Security identity
Names, identifiers, and filing context for this profile.
1 source field
Report period
Q3 2026
Institutions
2
Top holders
2
XFOR full security history
Ownership snapshot
Full 13F holder table
X4 Pharmaceuticals, Inc SEC filings
X4 Pharmaceuticals, Inc company facts
Broader feeds
Reporting periods
Holder history for CUSIP 98420X202
Recent filing periods:
Ownership snapshot
Top reported holders of XFOR - X4 Pharmaceuticals, Inc - COMMON STOCK (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.
Comparable stake leader
MORGAN STANLEY
Disclosed value leader
MORGAN STANLEY
Comparable rows
15/15
Latest evidence
14 Sep 2026
13F
13D/G
Lead comparable stake: 10%
13D/G row: MORGAN STANLEY
Showing 1-6 of 15 holder rows.
Quick read
MORGAN STANLEY leads the comparable SEC ownership view at 10%.
15 of 15 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.
Open SEC evidence
Opens MORGAN STANLEY's linked filing trail.
Comparable ownership
Top 5
MORGAN STANLEY
10%
Empery Asset Management, LP
10%
Coastlands Capital LP
10%
Deep Track Capital, LP
8.3%
PERCEPTIVE ADVISORS LLC
8.1%
Ownership % is shown only when SEC disclosures are safely comparable across share classes.
Detailed SEC evidence table Showing 1-6 of 15 holder rows
| Holder | Evidence | Ownership % | Position | 12M Net Δ | As of |
|---|---|---|---|---|---|
| MORGAN STANLEY |
13F
13D/G
Company
|
10%
from 13D/G
|
$44,184,173
9,461,279 shares
|
— | 30 Jun 2026 |
| Empery Asset Management, LP |
13D/G
13F
Company
|
10%
|
$35,180,748
9,043,894 shares
|
+$25,462,897 | 31 Dec 2025 |
| Coastlands Capital LP |
13D/G
|
10%
|
$7,773,911
2,491,638 shares
|
+$37,418 | 03 Oct 2025 |
| Deep Track Capital, LP |
13D/G
13F
Company
|
8.3%
|
$35,460,343
8,040,894 shares
|
+$25,021,895 | 30 Jun 2026 |
| PERCEPTIVE ADVISORS LLC |
13F
13D/G
Company
|
8.1%
from 13D/G
|
$37,049,403
7,933,491 shares
|
— | 30 Jun 2026 |
| Saturn V Capital Management LP |
13F
13D/G
Company
|
7.4%
from 13D/G
|
$32,565,512
6,973,343 shares
|
— | 30 Jun 2026 |
How to read this table
Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
13F holder rows
Institutional holders as of Q3 2026
Investor-level positions for this CUSIP, loaded as an interactive table.
Institutions
2
Shares
1,174
Rows available
2
| Investor | Option | Weight % | Change % | SEC-reported value | * Price | Shares | Share Change | Activity | Report Period |
|---|
* SEC-reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that did not pass the local price check.
Compare Q3 2026 vs Q2 2026 Across Filers
Q2 2026 holders
88
Q3 2026 holders
2
Holder diff
-86
| Investor | Q2 2026 Shares | Q3 2026 Shares | Share Diff | Share Chg % | Q2 2026 value | Q3 2026 value | Value change | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend